|
TMEM97 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.36299999997647E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.419800E-03 |
| Normal-vs-Stage2 |
2.09419999996907E-06 |
| Normal-vs-Stage3 |
1.36200000167008E-08 |
| Normal-vs-Stage4 |
1.85920999999922E-05 |
| Stage1-vs-Stage2 |
4.379500E-03 |
| Stage1-vs-Stage3 |
8.06700000000049E-05 |
| Stage1-vs-Stage4 |
4.841500E-03 |
| Stage2-vs-Stage3 |
9.226600E-01 |
| Stage2-vs-Stage4 |
7.858000E-01 |
| Stage3-vs-Stage4 |
6.888200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.3420999995547E-07 |
| Normal-vs-AfricanAmerican |
3.161900E-02 |
| Normal-vs-Asian |
2.778000E-01 |
| Caucasian-vs-AfricanAmerican |
2.929200E-01 |
| Caucasian-vs-Asian |
5.484200E-01 |
| AfricanAmerican-vs-Asian |
9.575000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.68399999950419E-07 |
| Normal-vs-Female |
3.045500E-04 |
| Male-vs-Female |
3.815000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.276400E-02 |
| Normal-vs-Age(41-60Yrs) |
3.4129000000549E-06 |
| Normal-vs-Age(61-80Yrs) |
1.6983199999987E-05 |
| Normal-vs-Age(81-100Yrs) |
1.454160E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.158400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.958400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.151600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.633600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.660800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.672800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.474800E-01 |
| Normal-vs-Grade 2 |
4.392600E-04 |
| Normal-vs-Grade 3 |
1.26759999996562E-06 |
| Normal-vs-Grade 4 |
4.54150000051001E-07 |
| Grade 1-vs-Grade 2 |
6.425200E-01 |
| Grade 1-vs-Grade 3 |
2.301000E-01 |
| Grade 1-vs-Grade 4 |
7.519600E-02 |
| Grade 2-vs-Grade 3 |
1.864250E-02 |
| Grade 2-vs-Grade 4 |
1.302690E-03 |
| Grade 3-vs-Grade 4 |
1.758610E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.26429999999889E-05 |
| Normal-vs-ccB subtype |
3.68910000000389E-05 |
| ccA subtype-vs-ccB subtype |
3.495800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.04059999950223E-07 |
| Normal-vs-N1 |
4.295700E-02 |
| N0-vs-N1 |
8.538200E-01 |
|
|
